Jorge Sanchez
Neurology · Sioux Falls, SDNPI 1295701506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,167 and has fallen 63.1% since, to $431 in 2022.
Across 192 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$438
- Novartis$356
- AstraZeneca$339
- Greenwich Biosciences, Inc.$332
- AbbVie$236
- UCB, Inc.$211
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,16899%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 27 | $438 |
| Novartis | 19 | $356 |
| AstraZeneca | 28 | $339 |
| Greenwich Biosciences, Inc. | 10 | $332 |
| AbbVie(2 entities) | 15 | $236 |
| UCB, Inc. | 11 | $211 |
| Lundbeck LLC | 8 | $140 |
| Amgen | 7 | $118 |
| Sanofi | 7 | $93 |
| Livanova USA, Inc. | 3 | $84 |
| Kyowa Kirin, Inc. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Biogen | 4 | $64 |
| Harmony Biosciences LLC | 4 | $63 |
| Eisai Inc. | 3 | $57 |
| Travere Therapeutics, Inc. | 6 | $53 |
| Acadia Pharmaceuticals Inc | 4 | $53 |
| Upsher-smith Laboratories LLC | 3 | $49 |
| CSL Behring | 3 | $49 |
| Aquestive Therapeutics, Inc. | 2 | $39 |
| Bristol Myers Squibb | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Zogenix Inc. | 2 | $28 |
| EMD Serono, Inc. | 2 | $27 |
| Adamas Pharmaceuticals, Inc. | 1 | $20 |
| GE HealthCare | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Catalyst Pharmaceuticals, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Grifols USA, LLC | 1 | $12 |
| SK Life Science, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$250
How this compares
$3,186 in reported general payments places this provider in the 75th percentile of 49 neurology providers in South Dakota.
Other neurology in Sioux Falls
- Andrew RidderSioux Falls$97K
- Wijdan RaiSioux Falls$81K
- Jeffrey BoyleSioux Falls$14K
- Mehwish FarooqiSioux Falls$12K
- Bassel SalemSioux Falls$7K
- Cynthia Zevallos MauSioux Falls$6K
- Karan TopiwalaSioux Falls$4K
- Nessim AminSioux Falls$1K
- Lisa ViolaSioux Falls$1K
- Xi WangSioux Falls$982
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.